Collaborative Neuroscience Network

Center Information

Collaborative Neuroscience Network
12772 Valley View Street, Suite 3
Garden Grove, CA 92845
866-267-2145

Craig Leach
Senior Director of Business Development
Phone: 512-565-1573
Email:craigleach@cnstrial.com
www.cnstrial.com

Currently Enrolling Trials

[Show More]

Therapeutic Areas

Devices
Endocrinology
Family Medicine
Genetic Disease
Healthy Volunteers
Internal Medicine
Neurology
Nutrition and Weight Loss
Psychiatry/Psychology
Sleep

Performance Metrics

Number of Studies Conducted: 700
Number of Active Patients in the Database: 100,000
Average Number of Total Patients Enrolled: 1100
Average Percent of Total Patients Randomized: 75%
Average Percent of ‘Completed’ Studies that met Enrollment Goals: 95%
EDC Capabilities: Yes

Staff Certifications
Number of Certified CRCs: 5

Center Overview:

Collaborative Neuroscience has been in business since 2001. We are a privately owned, 60-bed Phase 1 clinical pharmacology unit, plus 3 outpatient sites located in California. The mission of CNS is to advance medical knowledge through seamless execution of complex clinical trials utilizing our extensive experience, knowledge, and capabilities.

Research experience:

Since our opening in 2001, we have worked with most major CROs and a wide range of sponsors from small biotechs to the largest pharma companies in the world. We specialize in Psychiatric and Neurological disorders but have a wide range of experience in other indications and normal healthy volunteer studies. 

Facility description:

A state of the art 60-bed, clinical pharmacology unit. Experts in complex clinical trials. Additionally, with our four sites, we offer both inpatient and outpatient capabilities. Located in the Los Angeles metropolitan area, we have access to a huge potential patient population. Our easily accessible sites are located near public transportation. Additionally, we employee four vans, drivers, and a full time transportation coordinator to insure that study participants can arrive at the sites in a timely manner.

Investigator experience:

David P. Walling, Ph.D., Chief Executive Officer, and Principal Investigator, Psychiatry

Armen Goenjian, M.D., CMO, and Principal Investigator, Board Certified in Psychiatry

Mark Leibowitz, M.D., Medical Director of Early Phase Research and Principal Investigator, Board Certified in Internal Medicine

Nirav Patel, M.D., Principal Investigator, Board Certified in Neurology

Omid Omidvar, M.D., Principal Investigator, Board Certified in Neurology

Steven H. Reynolds, D.O., Principal Investigator, Board Certified in Family Practice

Lara Shirikjian, D.O., Principal Investigator, Board Certified in Psychiatry

Haig Goenjian, MD., Principal Investigator, Board Certified Psychiatrist

Staff expertise:

David P. Walling, Ph.D., Chief Executive Officer, and Principal Investigator, Psychiatry - 20+ years of research experience

Larry Ereshefsky, Ph.D., Chief Scientific Officer - 20+ years of experience

Patient demographics:

Total Number48,000
Healthy (Including Asian, elderly10,000
ADHD1,000
Alzheimer's2,000
Bipolar1,000
Depression3,000
Diabetes2,200
Migraine2,000
Multiple Sclerosis700
Pain1,000
Parkinson's1,500
Schizophrenia8,000
Smokers1,000

Other information:

We have four validated driving simulators and are experts in impaired driving studies. We have also successfully conducted Asian bridging studies

Contact Center

If you are interested in contacting this center to discuss clinical trials, please complete and send the email form below. A representative from the research center will then follow up with you.